These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
400 related articles for article (PubMed ID: 12365879)
21. [Specialised first-episode psychosis services: a systematic review of the literature]. Skalli L; Nicole L Encephale; 2011 May; 37 Suppl 1():S66-76. PubMed ID: 21600336 [TBL] [Abstract][Full Text] [Related]
22. Remission in early psychosis: Rates, predictors, and clinical and functional outcome correlates. Emsley R; Rabinowitz J; Medori R; Schizophr Res; 2007 Jan; 89(1-3):129-39. PubMed ID: 17095194 [TBL] [Abstract][Full Text] [Related]
23. Early intervention in patients at ultra high risk of psychosis: benefits and risks. de Koning MB; Bloemen OJ; van Amelsvoort TA; Becker HE; Nieman DH; van der Gaag M; Linszen DH Acta Psychiatr Scand; 2009 Jun; 119(6):426-42. PubMed ID: 19392813 [TBL] [Abstract][Full Text] [Related]
24. Triiodothyronine accelerates and enhances the antipsychotic effect of risperidone in acute schizophrenia. Steibliene V; Bunevicius A; Savickas A; Prange AJ; Nemeroff CB; Bunevicius R J Psychiatr Res; 2016 Feb; 73():9-16. PubMed ID: 26679760 [TBL] [Abstract][Full Text] [Related]
25. Early use of clozapine for poorly responding first-episode psychosis. Agid O; Remington G; Kapur S; Arenovich T; Zipursky RB J Clin Psychopharmacol; 2007 Aug; 27(4):369-73. PubMed ID: 17632221 [TBL] [Abstract][Full Text] [Related]
26. Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: study design and baseline characteristics. Phillips LJ; Nelson B; Yuen HP; Francey SM; Simmons M; Stanford C; Ross M; Kelly D; Baker K; Conus P; Amminger P; Trumpler F; Yun Y; Lim M; McNab C; Yung AR; McGorry PD Aust N Z J Psychiatry; 2009 Sep; 43(9):818-29. PubMed ID: 19670055 [TBL] [Abstract][Full Text] [Related]
28. Suicide prevention in first episode psychosis: the development of a randomised controlled trial of cognitive therapy for acutely suicidal patients with early psychosis. Power PJ; Bell RJ; Mills R; Herrman-Doig T; Davern M; Henry L; Yuen HP; Khademy-Deljo A; McGorry PD Aust N Z J Psychiatry; 2003 Aug; 37(4):414-20. PubMed ID: 12873325 [TBL] [Abstract][Full Text] [Related]
29. Cognitive-behavioural therapy in first-episode and early schizophrenia. 18-month follow-up of a randomised controlled trial. Tarrier N; Lewis S; Haddock G; Bentall R; Drake R; Kinderman P; Kingdon D; Siddle R; Everitt J; Leadley K; Benn A; Grazebrook K; Haley C; Akhtar S; Davies L; Palmer S; Dunn G Br J Psychiatry; 2004 Mar; 184():231-9. PubMed ID: 14990521 [TBL] [Abstract][Full Text] [Related]
30. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Amminger GP; Schäfer MR; Papageorgiou K; Klier CM; Cotton SM; Harrigan SM; Mackinnon A; McGorry PD; Berger GE Arch Gen Psychiatry; 2010 Feb; 67(2):146-54. PubMed ID: 20124114 [TBL] [Abstract][Full Text] [Related]
31. Risperidone for psychosis of Alzheimer's disease and mixed dementia: results of a double-blind, placebo-controlled trial. Brodaty H; Ames D; Snowdon J; Woodward M; Kirwan J; Clarnette R; Lee E; Greenspan A Int J Geriatr Psychiatry; 2005 Dec; 20(12):1153-7. PubMed ID: 16315159 [TBL] [Abstract][Full Text] [Related]
32. Who needs antipsychotic medication in the earliest stages of psychosis? A reconsideration of benefits, risks, neurobiology and ethics in the era of early intervention. Francey SM; Nelson B; Thompson A; Parker AG; Kerr M; Macneil C; Fraser R; Hughes F; Crisp K; Harrigan S; Wood SJ; Berk M; McGorry PD Schizophr Res; 2010 Jun; 119(1-3):1-10. PubMed ID: 20347270 [TBL] [Abstract][Full Text] [Related]
33. [Risperidone in the early treatment of first-episode psychosis: a two-year follow-up study]. Gutiérrez Fraile M; Segarra Echevarría R; González-Pinto Arrillaga A; Martínez Junquera G Actas Esp Psiquiatr; 2002; 30(3):142-52. PubMed ID: 12106515 [TBL] [Abstract][Full Text] [Related]
34. Ndel1 oligopeptidase activity as a potential biomarker of early stages of schizophrenia. Dal Mas C; Nani JV; Noto C; Yonamine CM; da Cunha GR; Mansur RB; Ota VK; Belangero SI; Cordeiro Q; Kapczinski F; Brietzke E; Bressan RA; Gadelha A; Hayashi MAF Schizophr Res; 2019 Jun; 208():202-208. PubMed ID: 30857875 [TBL] [Abstract][Full Text] [Related]
35. Obsessive-compulsive symptoms in a randomized, double-blind study with olanzapine or risperidone in young patients with early psychosis. van Nimwegen L; de Haan L; van Beveren N; Laan W; van den Brink W; Linszen D J Clin Psychopharmacol; 2008 Apr; 28(2):214-8. PubMed ID: 18344733 [TBL] [Abstract][Full Text] [Related]
36. [Detection and early treatment of subjects at high risk of clinical psychosis: Definitions and recommendations]. Michel C; Toffel E; Schmidt SJ; Eliez S; Armando M; Solida-Tozzi A; Schultze-Lutter F; Debbané M Encephale; 2017 May; 43(3):292-297. PubMed ID: 28347521 [TBL] [Abstract][Full Text] [Related]
37. Treating co-occurring first-episode psychosis and borderline personality: a pilot randomized controlled trial. Gleeson JF; Chanen A; Cotton SM; Pearce T; Newman B; McCutcheon L Early Interv Psychiatry; 2012 Feb; 6(1):21-9. PubMed ID: 22379625 [TBL] [Abstract][Full Text] [Related]
38. Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison. Keefe RS; Sweeney JA; Gu H; Hamer RM; Perkins DO; McEvoy JP; Lieberman JA Am J Psychiatry; 2007 Jul; 164(7):1061-71. PubMed ID: 17606658 [TBL] [Abstract][Full Text] [Related]
39. A randomized controlled trial of cognitive-behavioral therapy for persistent symptoms in schizophrenia resistant to medication. Sensky T; Turkington D; Kingdon D; Scott JL; Scott J; Siddle R; O'Carroll M; Barnes TR Arch Gen Psychiatry; 2000 Feb; 57(2):165-72. PubMed ID: 10665619 [TBL] [Abstract][Full Text] [Related]
40. Programma 2000: celebrating 10 years of activity of an Italian pilot programme on early intervention in psychosis. Cocchi A; Meneghelli A; Preti A Aust N Z J Psychiatry; 2008 Dec; 42(12):1003-12. PubMed ID: 19016088 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]